Safety and efficacy of trofinetide in Rett syndrome: a systematic review and meta-analysis of randomized controlled trials
Abstract Introduction Rett syndrome is a rare genetic neurodevelopmental disorder that predominantly impacts females. It presents with loss of acquired skills, impaired communication, and stereotypic hand movements. Given the limited treatment options for Rett syndrome, there is a dire need for effe...
Main Authors: | Abdallah Abbas, Aya M Fayoud, Mostafa Hossam El Din Moawad, Abdullah Ashraf Hamad, Heba Hamouda, Eman A. Fouad |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12887-024-04526-3 |
Similar Items
-
Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need
by: Shuaibu A. Hudu, et al.
Published: (2023-08-01) -
Development of trofinetide for the treatment of Rett syndrome: from bench to bedside
by: Melissa Kennedy, et al.
Published: (2024-01-01) -
Rett Syndrome and the Role of MECP2: Signaling to Clinical Trials
by: Adele Gaspar Lopes, et al.
Published: (2024-01-01) -
A review of the Rett Syndrome Behaviour Questionnaire and its utilization in the assessment of symptoms associated with Rett syndrome
by: Alan K. Percy, et al.
Published: (2023-07-01) -
Trofinetide—a new chapter in rett syndrome’s treatment
by: Muhammad Furqan
Published: (2023-11-01)